Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma
Condition(s):Advanced Malignant Pleural or Peritoneal MesotheliomaLast Updated:July 9, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Malignant Pleural or Peritoneal MesotheliomaLast Updated:July 9, 2020Not yet recruiting
Condition(s):Ovarian CancerLast Updated:February 7, 2024Recruiting
Condition(s):Laryngeal Cancer Stage II; Laryngeal Cancer Stage III; Carcinoma, Squamous Cell; Head and Neck NeoplasmsLast Updated:November 7, 2023Active, not recruiting
Condition(s):Ovarian Cancer; Ovarian and Fallopian Tube Cysts and Neoplasms; Neoplasms by Site; Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Carcinoma, Ovarian Epithelial; Ovarian Diseases; Adnexal Diseases; Genital Diseases, Female; Carcinoma; Anlotinib; PARP Inhibitors; BRCA1 Mutation; Angiogenesis; Antineoplastic Agents; BRCA2 MutationLast Updated:October 30, 2020Unknown status
Condition(s):Pancreatic CancerLast Updated:September 28, 2023Terminated
Condition(s):Pancreatic Acinar Cell CarcinomaLast Updated:January 22, 2024Recruiting
Condition(s):Pancreatic CancerLast Updated:February 13, 2024Active, not recruiting
Condition(s):Solid TumorsLast Updated:January 26, 2024Active, not recruiting
Condition(s):Ovarian CancerLast Updated:September 23, 2022Completed
Condition(s):NeoplasmsLast Updated:August 7, 2023Suspended
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.